File(s) under permanent embargo
Marine anticancer drugs and their relevant targets: a treasure from the ocean
journal contribution
posted on 2019-06-01, 00:00 authored by M Nigam, Hafiz SuleriaHafiz Suleria, M H Farzaei, A P MishraMarine organisms comprising animals and plants are wealthiest sources of bioactive compounds possessing various pharmacological properties specifically: free radical scavenging, antitumor, antimicrobial, analgesic, neuroprotective and immunomodulatory. Marine drugs provide an alternative source to meet the demand of effective, safe and low-cost drugs that are rising with the continuously growing world population. Cancer is one of the leading reasons of mortality in western nations in contrast to communicable diseases of developing nations. In spite of outstanding developments in cancer therapy in past three decades, there is still an insistent necessity for innovative drugs in the area of cancer biology, especially in the unexplored area of marine anticancer compounds. However, recent technological innovations in structure revelation, synthetic creation of new compounds and biological assays have made possible the isolation and clinical assessment of innumerable unique anticancer compounds from marine environment. This review provides an insight into the anticancer research so far conducted in the area of the marine natural products/synthetic derivatives, their possible molecular targets and the current challenges in the drug development.
History
Journal
DARU journal of pharmaceutical sciencesVolume
27Issue
1Pagination
491 - 515Publisher
SpringerLocation
Cham, SwitzerlandPublisher DOI
ISSN
1560-8115eISSN
2008-2231Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2019, Springer Nature Switzerland AGUsage metrics
Categories
No categories selectedKeywords
Marine bioactive compoundsAntiproliferationCell deathCytotoxicApoptosisAutophagyScience & TechnologyLife Sciences & BiomedicinePharmacology & PharmacyHISTONE DEACETYLASE INHIBITORSCELL-DEATHCYTOTOXIC PEPTIDESIMMUNOSUPPRESSIVE COMPOUNDMULTIDRUG-RESISTANCEBRENTUXIMAB VEDOTINBIOACTIVE COMPOUNDSMEDIATED APOPTOSISANTITUMOR-ACTIVITYKINASE ACTIVATION